KRAS and cancer: Their analysis also demonstrated a numerically lower but statistically nonsignificant incidence of KRAS variants among patients with YO cancer.4 In contrast, Watson et al8 in 2016 reported a higher incidence of KRAS variants in YO cancers (also defined as diagnosis at age <40 years), although this finding was compromised by a smaller sample size.